CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program
Who's in front heading 'round the bend?
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.
Many funds' fortunes have turned amid these stocks' volatility.
Plus, Vanguard says 401(k) investors stayed the course in 2008, Macquarie Group buys Delaware Investments, more leveraged ETF warnings, and more.